Bland, J. M. & Altman, T. J. (1986) Statistical methods for assessing agreement between two methods of clinical measurement. Lancet, i, 307–310.
Carles, R. A., Blumentahl, J. A. & Sherwood, A. (1998) Effect of satisfaction with social support on blood pressure in normotensive and borderline hypertensive men and women. International Journal of Behavioral Medicine, 5, 76–85.
Clark, D. B., Feske, U., Masia, C. L., et al (1997) Systematic assessment of social phobia in clinical practice. Depression and Anxiety, 6, 47–61.
Cohen, J. (1988) Statistical Power Analysis for the Behavioral Sciences (2nd edn), pp. 182–183. NJ: Erlbaum
Davidson, J. R. T., Miner, C. M., DeVeaugh-Geiss, J., et al (1997) The Brief Social Phobia Scale: a psychometric evaluation. Psychological Medicine, 27, 161–166.
Dixon, J. J., de Monchaux, C. & Sandler, J. (1957) Patterns of anxiety: an analysis of social anxieties. British Journal of Medical Psychology, 30, 107–112.
Guy, W., (ed.) (1976) ECDEU Assessment Manual for Psychopharmacology: Publication ADM 76–338, pp. 207–222. Washington, DC: US Department of Health, Education, and Welfare
Kessler, R. C., McConagle, K. A., Zhao, S., et al (1994) Lifetime and 12-month prevalence of DSM–III–R psychiatric disorders in the United States: results from the National Comorbidity Survey. Archives of General Psychiatry, 51, 8–19.
Liebowitz, M. R. (1987) Social Phobia. In Anxiety (ed. Klein, D. F.), pp. 141–173. Basel: Karger.
Marks, I. M. & Mathews, A. M. (1979) Brief standard self-rating for phobic patients. Behavior Research and Therapy, 17, 263–267.
Mattick, R. P. & Clarke, J. C. (1992) Assessment of anxiety in social interaction and being observed by others: the Social Interaction and Anxiety Scale and the Social Phobia Scale. Behavior Therapy, 23, 53–73.
Pande, A. C., Davidson, J. R., Jefferson, J. W., et al (1999) Treatment of social phobia with gabapentin: a placebo-controlled study. Journal of Clinical Psychopharmacology, 19, 341–348.
Sheehan, D. (1983) The Anxiety Disease, p. 138. New York: Bantam
Stein, M. B., Chartier, M. J., Hazen, A. L., et al (1996) Paroxetine in the treatment of generalized social phobia: open-label treatment and double-blind placebo-controlled discontinuation. Journal of Clinical Psychopharmacology, 16, 218–222.
Stein, M. B., Fyer, A. J., Davidson, J. R. T., et al (1999) Fluvoxamine treatment of social phobia (social anxiety disorder): a double-blind, placebo-controlled study. American Journal of Psychiatry, 156, 756–760.
Turner, S. M., Beidel, D. C., Dancu, C. V., et al (1989) An empirically derived inventory to measure social fears and anxiety: the Social Phobia and Anxiety Inventory. Psychological Assessment, 1, 35–40.
Van Vliet, I. M., den Boer, J. A. & Westenberg, H. G. M. (1994) Psychopharmacological treatment of social phobia: a double-blind placebo controlled study with fluvoxamine. Psychopharmacology, 115, 128–131.
Ware, J. E. Jr, & Sherbourne, C. D. (1992) The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Medical Care, 30, 473–483.
Watkins, L. L., Grossman, P., Krishnan, R. & Sherwood, A. (1998) Anxiety and vagal control of heart rate. Psychosomatic Medicine, 60, 498–502.
Watson, D. & Friend, R. (1969) Measurement of social evaluative society. Journal of Consulting and Clinical Psychology, 33, 448–457.